These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2758562)

  • 21. A weekly alternating chemotherapy regimen with low toxicity for the treatment of aggressive lymphoma.
    Bower M; Brock C; Gulliford T; O'Reilly SM; Smith DB; Newlands ES
    Cancer Chemother Pharmacol; 1996; 38(1):106-9. PubMed ID: 8603443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study.
    Rödel S; Engert A; Diehl V; Reiser M
    Leuk Lymphoma; 2005 Dec; 46(12):1729-34. PubMed ID: 16353313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomas.
    Smith DB; Ledermann JA; Boesen E; Newlands ES; Begent RH; Rustin GJ; Glaser MG; Bagshawe KD
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):991-4. PubMed ID: 2753060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
    Dreiher J; Shpilberg O; Raanani P; Chetrit A; Ben-Bassat I
    Leuk Res; 1998 Nov; 22(11):997-1002. PubMed ID: 9783801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP.
    Steinke B; Bross K; Reinold HM; Heim ME; Schalk KP; Heidemann E; Josten K; Arnold H; Manegold C; Hoffman I
    Eur J Cancer; 1992; 28(1):100-4. PubMed ID: 1373634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coeliac disease following high-dose chemotherapy.
    Stewart AJ; Southcott BM
    Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):494-6. PubMed ID: 12512973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose escalation of biweekly cyclophosphamide, doxorubicin, vincristine, and prednisolone using recombinant human granulocyte colony stimulating factor in non-Hodgkin's lymphoma.
    Tanosaki R; Okamoto S; Akatsuka N; Ishida A; Michikawa N; Masuda Y; Uchida H; Murata M; Kizaki M; Ikeda Y
    Cancer; 1994 Oct; 74(7):1939-44. PubMed ID: 7521788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
    Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
    Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas.
    Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS
    Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen.
    Herbrecht R; Ortiz S; Damonte JC; Liu KL; Maloisel F; Dufour P; Bergerat JP; Oberling F
    Hematol Oncol; 1991; 9(4-5):253-7. PubMed ID: 1720760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
    Longo DL; DeVita VT; Duffey PL; Wesley MN; Ihde DC; Hubbard SM; Gilliom M; Jaffe ES; Cossman J; Fisher RI
    J Clin Oncol; 1991 Jan; 9(1):25-38. PubMed ID: 1702144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P; Guilhot F; Bordesoule D; Renou P; Benz-Lemoine E; Fouillard L; Drouet M; Tanzer J; Lamagnere JP
    Haematologica; 1991; 76(6):479-84. PubMed ID: 1726492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
    Somers R; Carde P; Thomas J; Tirelli U; Keuning JJ; Bron D; Delmer A; de Bock R; De Wolf-Peeters C; Keunig JJ
    Ann Oncol; 1994; 5 Suppl 2():85-9. PubMed ID: 7515651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VB-CHEP chemotherapy regimen for aggressive non-Hodgkin's lymphomas.
    Yalçin S; Kars A; Ozişik Y; Tekuzman G; Ozyilkan O; Celik I; Barişta I; Güllü I; Güler N; Baltali E; Firat D
    Eur J Haematol; 1998 Oct; 61(4):261-5. PubMed ID: 9820633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
    Battista C; Panza N; Chiurazzi B; Iodice G; Esposito G; Cocorocchio E; Bevilacqua N; Pacilio G
    Biomed Pharmacother; 1993; 47(4):145-54. PubMed ID: 8018826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin's lymphoma.
    Shimizu K; Hara K; Kunii A
    Am J Clin Oncol; 1989 Jun; 12(3):195-200. PubMed ID: 2729176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
    Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.